University of Missouri develops first-ever vaccine for bovine anaplasmosis
Researchers at the University of Missouri have developed the first-ever vaccine proven to protect cattle from bovine anaplasmosis, a tick-borne disease that causes significant economic losses. The disease, common in Missouri, infects red blood cells, leading to nearly $1 billion in losses worldwide annually. Led by Roman Ganta, a professor at Mizzou's College of Veterinary Medicine, the team genetically modified the pathogen Anaplasma marginale to create the vaccine, which has successfully immunized cattle. This breakthrough aims to safeguard Missouri's $1.6 billion cattle industry and has potential global applications. Further research and collaboration with industry partners are underway for vaccine distribution.
